Generex Biotechnology Corporation
(NASDAQ:GNBT)|
0.32 -0.01 (-3.03%) Nov 20 - Close |
|
|
|
After-Hours 0.35 +0.03 (9.37%) Thu, 20 Nov 2008 6:50 PM
- Compare GNBT with:
- View: Line | Candlestick
Company Profile
Generex Biotechnology Corporation
33 Harbour Square
Toronto, Ontario, M5J 2G2
Canada - Map
Phone: (416) 364-2551
Fax: (416) 364-9363
Website: www.generex.com
State of incorporation: Delaware
CEO: Anna E. Gluskin
Employees: 27
Sector: Other
Industry Group: Other
Industry: Other
Engaged in the research drug delivery technology
The Company and its wholly-owned subsidiary Generex Pharmaceuticals, Inc. are engaged in the research and development of drug delivery systems and technology.
Recent news for GNBT
-
Generex Awarded New Pain Relief Patents
GlobeNewswire - Yesterday at 10:16 ET
-
GlobeNewswire - Nov 14 at 9:30 ET
-
CORRECTION -- Generex Biotechnology to Make Convertible Debenture Payment in Cash
GlobeNewswire - Nov 12 at 12:00 ET
-
Generex Biotechnology to Make Convertible Debenture Payment in Cash
GlobeNewswire - Nov 12 at 8:00 ET
-
GlobeNewswire - Nov 10 at 9:00 ET
-
Generex Oral-lyn(tm) Featured On XM Satellite Radio
GlobeNewswire - Nov 05 at 11:00 ET
-
Generex Biotechnology Submits Syrian Dossier
GlobeNewswire - Nov 05 at 7:00 ET
-
Generex Oral-lyn Featured at International Diabetes Conference
GlobeNewswire - Nov 04 at 8:00 ET
-
Generex Biotechnology Comments On New ADA/EASD Consensus Algorithm for Type 2 Diabetes Treatment
GlobeNewswire - Oct 30 at 8:00 ET
-
GlobeNewswire - Oct 29 at 8:00 ET
Top members owning GNBT
-
Top 73%
-51.25%3m:
-51.25%YTD:
-
Top 99%
-78.04%3m:
-80.30%YTD:
-
Top 70%
-49.92%3m:
-48.62%YTD: